Hematopoietic and Lymphoid Cell NeoplasmNCT05060328
Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia
An observational study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
This study investigates the use of Google Translate "Conversation Mode" translation service to improve communication about pain and nausea with Spanish-speaking patients who are recovering after surgery. Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
- What is being tested?
- Medical Device Usage and Evaluation and Survey Administration
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 22 Jun 2021to 22 Mar 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with scheduled surgery under general anesthesia and will require translation services as part of standard care
Who may be able to join
- Ability to provide written informed consent
- Patients between 18-80 years of age whose primary language is Spanish and will require translation services as part of standard care
- American Society of Anesthesiologists physical status (ASA) 1-3
- Are scheduled surgery under general anesthesia
- Ability to understand and complete all study questionnaires
Who cannot join
- Emergency surgery
- ASA >= 4
- Patients who do not require official translation services for consent purposes
- Patients who have chronic pain and/or are taking opioids chronically (daily intake for more than a month before surgery)
- Patients who undergo craniotomy
- Patients with a hearing impairment that prevents the ability to hear the recorded statements; and/or a cognitive impairment that would prevent them from completing post-op assessments
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia: A Pilot Feasibility Study
This study investigates the use of Google Translate "Conversation Mode" translation service to improve communication about pain and nausea with Spanish-speaking patients who are recovering after surgery. The Google Translate "Conversation Mode" translation application is designed to provide translation from one language to another and used to allow the nurse or study doctor to communicate with patients in Spanish by asking pre-prepared questions through an electronic device such as an iPad or iPhone. Google Translate "Conversation Mode" may facilitate assessment of pain and nausea after surgery in Spanish speaking patients.
Read the detailed description
PRIMARY OBJECTIVE:
- To determine the feasibility of Google Translate "Conversation Mode" use to assess postoperative surgical pain presence, location and intensity, and nausea presence and intensity in Spanish speaking patients in the post-anesthesia care unit (PACU).
SECONDARY OBJECTIVES:
- To evaluate the length of stay in PACU. II. To assess patient satisfaction with regards to pain/nausea experienced in PACU.
III. To determine nursing satisfaction with regards to the use of Google Translate "Conversation Mode".
OUTLINE:
Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes.
- Being tested
- Medical Device Usage and Evaluation, Survey Administration
- Medical subject headings
- Hematologic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Medical Device Usage and EvaluationOther
Use Google Translate "Conversation Mode" translation application.
Survey AdministrationOther
Complete survey
| Study group | Role | What they receive |
|---|---|---|
| Health services research (Google Translate Conversation Mode) | Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes. Receives: Other: Medical Device Usage and Evaluation; Other: Survey Administration |
What is being measured
The primary outcome is the main question the study is designed to answer.
Ability to respond to the questions when asked using Google Translate
The feasibility rate and its 95% confidence interval will be estimated.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Sep 2021
- Study start22 Jun 2021
- Primary completion22 Mar 2022
- Study completion22 Mar 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hematopoietic and Lymphoid Cell NeoplasmStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05060328
- Sponsor's protocol ID
- 2020-1345
- Other IDs
- NCI-2021-09116, 2020-1345
- Status last verified
- Mar 2022
- First submitted
- 15 Sep 2021
- Last updated
- 4 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General Anesthesia: A Pilot Feasibility Study
- ClinicalTrials.gov ID
- NCT05060328
- Acronym / sponsor ID
- 2020-1345
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Study start
- 22 Jun 2021 (actual)
- Primary completion
- 22 Mar 2022 (actual)
- Study completion
- 22 Mar 2022 (actual)
- First posted
- 29 Sep 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study investigates the use of Google Translate "Conversation Mode" translation service to improve communication about pain and nausea with Spanish-speaking patients who are recovering after surgery. The Google Translate "Conversation Mode" translation application is designed to provide translation from one language to another and used to allow the nurse or study doctor to communicate with patients in Spanish by asking pre-prepared questions through an electronic device such as an iPad or iPhone. Google Translate "Conversation Mode" may facilitate assessment of pain and nausea after surgery in Spanish speaking patients.
Detailed description
PRIMARY OBJECTIVE:
- To determine the feasibility of Google Translate "Conversation Mode" use to assess postoperative surgical pain presence, location and intensity, and nausea presence and intensity in Spanish speaking patients in the post-anesthesia care unit (PACU).
SECONDARY OBJECTIVES:
- To evaluate the length of stay in PACU. II. To assess patient satisfaction with regards to pain/nausea experienced in PACU.
III. To determine nursing satisfaction with regards to the use of Google Translate "Conversation Mode".
OUTLINE:
Patients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Health services research (Google Translate Conversation Mode) | – | Other: Medical Device Usage and Evaluation, Other: Survey AdministrationPatients use Google Translate "Conversation Mode" translation application before and after surgery. Patients also complete survey over 10 minutes. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with scheduled surgery under general anesthesia and will require translation services as part of standard care
Key inclusion criteria (5 listed)
- Ability to provide written informed consent
- Patients between 18-80 years of age whose primary language is Spanish and will require translation services as part of standard care
- American Society of Anesthesiologists physical status (ASA) 1-3
- Are scheduled surgery under general anesthesia
- Ability to understand and complete all study questionnaires
Key exclusion criteria (6 listed)
- Emergency surgery
- ASA >= 4
- Patients who do not require official translation services for consent purposes
- Patients who have chronic pain and/or are taking opioids chronically (daily intake for more than a month before surgery)
- Patients who undergo craniotomy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Medical Device Usage and EvaluationUse Google Translate "Conversation Mode" translation application. | Other | Health services research (Google Translate Conversation Mode) |
| Survey AdministrationComplete survey | Other | Health services research (Google Translate Conversation Mode) |
Primary outcome
Ability to respond to the questions when asked using Google Translate
Time frame: 1 year
The feasibility rate and its 95% confidence interval will be estimated.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2022.
- MD Anderson Cancer Center WebsiteLink provided by the sponsor.
Related trials for Hematopoietic and Lymphoid Cell Neoplasm
Not yet recruitingPhase 4
MACE and BTK Inhibitors
Hematologic Cancer, MACE
Recruiting
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
Solid Tumor, Adult, Solid Tumor, Childhood
Active, not recruitingPhase 2
Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)
Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
Active, not recruitingPhase 2
Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I)
Advanced Lymphoma, Advanced Malignant Solid Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Ability to respond to the questions when asked using Google Translate (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2022.